| Tretinoin | Approved Investigational Nutraceutical | NTNG2 | 84628 |
upregulated | Tretinoin results in increased expression of NTNG2 mRNA | 9q34.13 | |
| Tretinoin | Approved Investigational Nutraceutical | NTRK1 | 4914 |
downregulated | Tretinoin results in decreased expression of NTRK1 mRNA | 1q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NTRK2 | 4915 |
upregulated | Tretinoin results in increased expression of NTRK2 mRNA | 9q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | NUAK1 | 9891 |
downregulated | Tretinoin results in decreased expression of NUAK1 mRNA | 12q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NUB1 | 51667 |
upregulated | Tretinoin results in increased expression of NUB1 mRNA | 7q36.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NUCB2 | 4925 |
downregulated | Tretinoin results in decreased expression of NUCB2 mRNA | 11p15.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NUDT1 | 4521 |
downregulated | Tretinoin results in decreased expression of NUDT1 mRNA | 7p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NUDT16L1 | 84309 |
upregulated | Tretinoin results in increased expression of NUDT16L1 mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NUDT19 | 390916 |
upregulated | Tretinoin results in increased expression of NUDT19 mRNA | 19q13.11 | |
| Tretinoin | Approved Investigational Nutraceutical | NUDT21 | 11051 |
downregulated | Tretinoin results in decreased expression of NUDT21 mRNA | 16q13 | |
| Tretinoin | Approved Investigational Nutraceutical | NUDT4 | 11163 |
downregulated | Tretinoin results in decreased expression of NUDT4 mRNA | 12q22 | |
| Tretinoin | Approved Investigational Nutraceutical | NUDT7 | 283927 |
downregulated | Tretinoin results in decreased expression of NUDT7 mRNA | 16q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NUP54 | 53371 |
downregulated | Tretinoin results in decreased expression of NUP54 mRNA | 4q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NUP62CL | 54830 |
downregulated | Tretinoin results in decreased expression of NUP62CL mRNA | Xq22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NUPR1 | 26471 |
upregulated | Tretinoin results in increased expression of NUPR1 mRNA | 16p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | NUSAP1 | 51203 |
downregulated | Tretinoin results in decreased expression of NUSAP1 mRNA | 15q14 | |
| Tretinoin | Approved Investigational Nutraceutical | NUTF2 | 10204 |
downregulated | Tretinoin results in decreased expression of NUTF2 mRNA | 16q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | NXPH1 | 30010 |
downregulated | Tretinoin results in decreased expression of NXPH1 mRNA | 7p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | NXPH2 | 11249 |
upregulated | Tretinoin results in increased expression of NXPH2 mRNA | 2q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | OAS1 | 4938 |
upregulated | Tretinoin results in increased expression of OAS1 mRNA | 12q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | OAS2 | 4939 |
upregulated | Tretinoin results in increased expression of OAS2 mRNA | 12q24.13 | |
| Tretinoin | Approved Investigational Nutraceutical | OAZ2 | 4947 |
downregulated | Tretinoin results in decreased expression of OAZ2 mRNA | 15q22.31 | |
| Tretinoin | Approved Investigational Nutraceutical | OCLN | 100506658 |
upregulated | Tretinoin results in increased expression of OCLN mRNA | 5q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ODC1 | 4953 |
downregulated | Tretinoin metabolite results in decreased expression of ODC1 mRNA | 2p25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | ODC1 | 4953 |
downregulated | Tretinoin results in decreased expression of ODC1 mRNA | 2p25.1 | |